Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Molecular Therapy. Nucleic Acids|October 6, 2025
Molecular and imaging biomarker responses to brain mutant HTT lowering in a mouse model of Huntington diseaseNicholas S Caron, Jianjia Fan, Da Ma, et al.
Scientific Reports|February 26, 2021
Recursive ensemble feature selection provides a robust mRNA expression signature for myalgic encephalomyelitis/chronic fatigue syndromePaula I Metselaar, Lucero Mendoza-Maldonado, Andrew Yung Fong Li Yim, et al.
Journal of Neurotrauma|May 13, 2020
Vascular-Cognitive Impairment following High-Thoracic Spinal Cord Injury Is Associated with Structural and Functional Maladaptations in CerebrovasculatureRahul Sachdeva, Mengyao Jia, Shaoxun Wang, et al.
NMR in Biomedicine|November 11, 2014
MR elastography and diffusion-weighted imaging of ex vivo prostate cancer: quantitative comparison to histopathologyRamin S Sahebjavaher, Guy Nir, Louis O Gagnon, et al.
Angiogenesis|March 11, 2016
The differential effects of metronomic gemcitabine and antiangiogenic treatment in patient-derived xenografts of pancreatic cancer: treatment effects on metabolism, vascular function, cell proliferation, and tumor growthDonald T Yapp, May Q Wong, Alastair H Kyle, et al.
Journal of Neurotrauma|November 17, 2017
Transient Hypertension after Spinal Cord Injury Leads to Cerebrovascular Endothelial Dysfunction and FibrosisAaron A Phillips, Nusrat Matin, Mengyao Jia, et al.
Journal of Neurotrauma|February 6, 2024
Advanced Magnetic Resonance Imaging Biomarkers of the Injured Spinal Cord: A Comparative Study of Imaging and Histology in Human Traumatic Spinal Cord InjurySarah Morris, Taylor Swift-LaPointe, Andrew Yung, et al.
Brain : a Journal of Neurology|December 12, 2022
AAV5-miHTT-mediated huntingtin lowering improves brain health in a Huntington's disease mouse modelSarah B Thomson, Anouk Stam, Cynthia Brouwers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicinJennifer H E Baker, Jeffrey Lam, Alaistair H Kyle, et al.
Frontiers in Immunology|September 2, 2025
An exploratory single-cell analysis of peripheral blood mononuclear cells from vedolizumab-treated Crohn's disease patients identifies response-associated differences among the plasmacytoid dendritic cells and classical monocytesAndrew Yung Fong Li Yim, Ishtu Hageman, Vincent W Joustra, et al.
Pageof 3